Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2017 2
2019 2
2020 1
2021 3
2023 3
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Quality assurance of radiation therapy after breast-conserving surgery among patients in the BOOG 2013-08 trial.
Wintraecken VM, Boersma LJ, van Roozendaal LM, de Vries J, van Kuijk SMJ, Vane MLG, van Dalen T, van der Hage JA, Strobbe LJA, Linn SC, Lobbes MBI, Poortmans PMP, Tjan-Heijnen VCG, van de Vijver KKBT, Westenberg AH, de Wilt JHW, Smidt ML, Simons JM; BOOG 2013-08 group. Wintraecken VM, et al. Among authors: vane mlg. Radiother Oncol. 2024 Feb;191:110069. doi: 10.1016/j.radonc.2023.110069. Epub 2023 Dec 21. Radiother Oncol. 2024. PMID: 38141879 Free article. Clinical Trial.
Gene expression profiles in clinically T1-2N0 ER+HER2- breast cancer patients treated with breast-conserving therapy: their added value in case sentinel lymph node biopsy is not performed.
van Roozendaal LM, Vane MLG, Colier E, Strobbe LJA, de Boer M, Sonke G, Van Maaren MC, Smidt ML. van Roozendaal LM, et al. Among authors: vane mlg. Breast Cancer Res Treat. 2024 Jan;203(1):103-110. doi: 10.1007/s10549-023-07128-2. Epub 2023 Oct 5. Breast Cancer Res Treat. 2024. PMID: 37794289 Free PMC article.
TNM classification and the need for revision of pN3a breast cancer.
van Nijnatten TJA, Moossdorff M, de Munck L, Goorts B, Vane MLG, Keymeulen KBMI, Beets-Tan RGH, Lobbes MBI, Smidt ML. van Nijnatten TJA, et al. Among authors: vane mlg. Eur J Cancer. 2017 Jul;79:23-30. doi: 10.1016/j.ejca.2017.04.002. Eur J Cancer. 2017. PMID: 28458119
Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08).
van Roozendaal LM, Vane MLG, van Dalen T, van der Hage JA, Strobbe LJA, Boersma LJ, Linn SC, Lobbes MBI, Poortmans PMP, Tjan-Heijnen VCG, Van de Vijver KKBT, de Vries J, Westenberg AH, Kessels AGH, de Wilt JHW, Smidt ML. van Roozendaal LM, et al. Among authors: vane mlg. BMC Cancer. 2017 Jul 1;17(1):459. doi: 10.1186/s12885-017-3443-x. BMC Cancer. 2017. PMID: 28668073 Free PMC article. Clinical Trial.
11 results